Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $1.6 million.

  • Jaguar Health's Net Cash Flow rose 15585.2% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.5 million, marking a year-over-year decrease of 19516.63%. This contributed to the annual value of $1.6 million for FY2024, which is 6111.68% up from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's Net Cash Flow is $1.6 million, which was up 15585.2% from -$3.5 million recorded in Q2 2025.
  • Jaguar Health's 5-year Net Cash Flow high stood at $24.2 million for Q1 2021, and its period low was -$19.5 million during Q3 2021.
  • Over the past 5 years, Jaguar Health's median Net Cash Flow value was -$332000.0 (recorded in 2021), while the average stood at -$163315.8.
  • As far as peak fluctuations go, Jaguar Health's Net Cash Flow crashed by 207198.8% in 2022, and later skyrocketed by 184857.14% in 2023.
  • Jaguar Health's Net Cash Flow (Quarter) stood at $4.7 million in 2021, then tumbled by 210.05% to -$5.1 million in 2022, then surged by 162.16% to $3.2 million in 2023, then tumbled by 262.89% to -$5.2 million in 2024, then skyrocketed by 130.13% to $1.6 million in 2025.
  • Its Net Cash Flow was $1.6 million in Q3 2025, compared to -$3.5 million in Q2 2025 and -$2.4 million in Q1 2025.